Gene · 4920
Papers2,066
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,066
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Small-molecule inhibitors of kinases in breast cancer therapy: recent advances, opportunities, and challenges. | Front Pharmacol | 2023 | 37711177 | PubTator, text mining | PubMed |
| Characterization of Fibrodysplasia Ossificans Progessiva relevant Acvr1/Acvr2 Activin receptors in medaka (Oryzias latipes). | PLoS One | 2023 | 37708126 | PubTator, text mining | PubMed |
| Rho family small GTPase Rif regulates Wnt5a-Ror1-Dvl2 signaling and promotes lung adenocarcinoma progression. | J Biol Chem | 2023 | 37703992 | PubTator, text mining | PubMed |
| Systematic development of a set of implementation strategies for transitional care innovations in long-term care. | Implement Sci Commun | 2023 | 37641112 | PubTator, text mining | PubMed |
| Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression. | EXCLI J | 2023 | 37636026 | PubTator, text mining | PubMed |
| Osteophyte Bridge Formation Correlates with Vascular Calcification and Cardiovascular Disease in Diffuse Idiopathic Skeletal Hyperostosis. | J Clin Med | 2023 | 37629454 | PubTator, text mining | PubMed |
| BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. | Cancers (Basel) | 2023 | 37627054 | PubTator, text mining | PubMed |
| Postbiotics in oncology: science or science fiction? | Front Microbiol | 2023 | 37608943 | PubTator, text mining | PubMed |
| A cell cycle centric view of tumour dormancy. | Br J Cancer | 2023 | 37608096 | PubTator, text mining | PubMed |
| Epigenetic insights into colorectal cancer: comprehensive genome-wide DNA methylation profiling of 294 patients in Korea. | BMB Rep | 2023 | 37574809 | PubTator, text mining | PubMed |
| Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling. | Int J Mol Sci | 2023 | 37569547 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates for Breast Cancer Treatment: Emerging Agents, Targets and Future Directions. | Int J Mol Sci | 2023 | 37569276 | PubTator, text mining | PubMed |
| ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer. | Cell Rep | 2023 | 37552603 | PubTator, text mining | PubMed |
| A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression. | Front Oncol | 2023 | 37546393 | PubTator, text mining | PubMed |
| Network topology and movement cost, not updating mechanism, determine the evolution of cooperation in mobile structured populations. | PLoS One | 2023 | 37527254 | PubTator, text mining | PubMed |
| Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death. | J Clin Invest | 2023 | 37526081 | PubTator, text mining | PubMed |
| ESS2 controls prostate cancer progression through recruitment of chromodomain helicase DNA binding protein 1. | Sci Rep | 2023 | 37524814 | PubTator, text mining | PubMed |
| Short histological kaleidoscope - recent findings in histology. Part III. | Rom J Morphol Embryol | 2023 | 37518868 | PubTator, text mining | PubMed |
| Antibody-Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond-A 2023 Review. | Curr Oncol | 2023 | 37504334 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4920/papers?page=9